# HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic
Canonical URL: https://biopharmsignal.com/news/BEAT/heartbeam-initiates-pilot-study-of-first-on-demand-12-lead-ecg-patch-to-detect-ischemia-outside-the-clinic
Ticker: BEAT
Company: HeartBeam
Source: HeartBeam
Published: 2026-05-11 12:31 EST
Original Source URL: https://ir.heartbeam.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-07-14 11:00 EST — [HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device](https://biopharmsignal.com/news/BEAT/heartbeam-awarded-new-u-s-patent-expanding-acoustic-sensing-and-fluid-monitoring-e0c78764) — Source: HeartBeam
- 2026-06-30 11:00 EST — [HeartBeam Completes Enrollment in Heart Attack Detection Pilot Study Ahead of Schedule](https://biopharmsignal.com/news/BEAT/heartbeam-completes-enrollment-in-heart-attack-detection-pilot-study-ahead-of-sc-c3aedd75) — Source: HeartBeam
- 2026-06-24 20:05 EST — [HeartBeam Announces Strategic Shift to Accelerate Global Adoption of its Ambulatory ECG Signal Platform and Leadership Transition](https://biopharmsignal.com/news/BEAT/heartbeam-announces-strategic-shift-to-accelerate-global-adoption-of-its-ambulat-2e1e9ad3) — Source: HeartBeam
- 2026-06-02 11:00 EST — [HeartBeam Announces New Peer-Reviewed Article Demonstrating Potential to Help Identify Heart Attack Risk at Home](https://biopharmsignal.com/news/BEAT/heartbeam-announces-new-peer-reviewed-article-demonstrating-potential-to-help-identify-heart-attack-risk-at-home) — Source: HeartBeam
- 2026-05-13 20:01 EST — [HeartBeam Reports First Quarter 2026 Results](https://biopharmsignal.com/news/BEAT/heartbeam-reports-first-quarter-2026-results) — Source: HeartBeam
## Related News
- 2026-07-22 20:15 EST — BFRG — [BullFrog AI to Participate in the BTIG Virtual Biotechnology Conference](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-the-btig-virtual-biotechnology-conference-5880a10e)
- 2026-07-22 20:05 EST — AZTA — [Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast](https://biopharmsignal.com/news/AZTA/azenta-announces-fiscal-2026-third-quarter-conference-call-and-webcast-48419fff)
- 2026-07-22 20:05 EST — VKTX — [Viking Therapeutics to Report Financial Results for Second Quarter 2026 on July 29, 2026](https://biopharmsignal.com/news/VKTX/viking-therapeutics-to-report-financial-results-for-second-quarter-2026-on-july--bbf2553f)
- 2026-07-22 20:01 EST — AXON — [Axon to Release Second Quarter 2026 Earnings on August 5, 2026](https://biopharmsignal.com/news/AXON/axon-to-release-second-quarter-2026-earnings-on-august-5-2026-66120902)
- 2026-07-22 12:39 EST — ARTL — [New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition](https://biopharmsignal.com/news/ARTL/new-analysis-of-over-50-studies-showed-that-all-the-non-prescription-cbd-product-a3445432)